Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior

Nature Neuroscience

Volumn 6, Issue 2, 2003, Pages 168-174

  Pawlak, Robert ^a   Magarinos, Ana Maria ^a   Melchor, Jerry ^a   McEwen, Bruce ^a   Strickland, Sidney ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STRESS;

AMYGDALA; ANIMALS; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; CORTICOSTERONE; FEMALE; GAP-43 PROTEIN; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; NEURAL PATHWAYS; NEURONAL PLASTICITY; NEURONS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESTRAINT, PHYSICAL; STRESS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0037314824     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn998     Document Type: Article

References (46)

1. Selye, H. A syndrome produced by diverse nocuous agents. Nature 138, 32 (1936).
2. Holsboer, F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 33, 181-214 (1999).
3. Allen, J.P. & Allen, C.F. Role of the amygdaloid complexes in the stress-induced release of ACTH in the rat. Neuroendocrinology 15, 220-230 (1974).
4. Rogan, M.T. & LeDoux, J.E. Emotion: systems, cells, synaptic plasticity. Cell 85, 469-475 (1996).
5. McEwen, B.S. Corticosteroids and hippocampal plasticity. Ann. NY Acad. Sci. 746, 134-142 (1994).
6. Lisman, J.E. Relating hippocampal circuitry to function: recall of memory sequences by reciprocal dentate-CA3 interactions. Neuron 22, 233-242 (1999).
7. Magarinos, A.M., Verdugo, J.M. & McEwen, B.S. Chronic stress alters synaptic terminal structure in hippocampus. Proc. Natl. Acad. Sci. USA 94, 14002-14008 (1997).
8. Vyas, A., Mitra, R., Shankaranarayana Rao, B.S. & Chattarji, S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 22, 6810-6818 (2002).
9. Chen, Z.L. & Strickland, S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917-925 (1997).
10. Baranes, D. et al. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21, 813-825 (1998).
11. Nicole, O. et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat. Med. 7, 59-64 (2001).
12. Mars, W.M., Zarnegar, R. & Michalopoulos, G.K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol. 143, 949-958 (1993).
13. Sappino, A.P. et al. Extracellular proteolysis in the adult murine brain. J. Clin. Invest. 92, 679-685 (1993).
14. Qian, Z., Gilbert, M.E., Colicos, M.A., Kandel, E.R. & Kuhl, D. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361, 453-457 (1993).
15. Tsirka, S.E., Rogove, A.D. & Strickland, S. Neuronal cell death and tPA. Nature 384, 123-124 (1996).
16. Tsirka, S.E., Gualandris, A., Amaral, D.G. & Stricldand, S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377, 340-344 (1995).
17. Madani, R. et al. Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO J. 18, 3007-3012 (1999).
18. Salles, F.J. & Strickland, S. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J. Neurosci. 22, 2125-2134 (2002).
19. Gray, T.S., Carney, M.E. & Magnuson, D.J. Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 50, 433-446 (1989).
20. Herman, J.P., Prewitt, C.M. & Cullinan, W.E. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit. Rev. Neurobiol. 10, 371-394 (1996).
21. Hastings, G.A. et al. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J. Biol. Chem. 272, 33062-33067 (1997).
22. Yamamoto, K. et al. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals. Proc. Natl. Acad. Sci. USA 99, 890-895 (2002).
23. Adams, J.P. & Sweatt, J.D. Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu. Rev. Pharmacol. Toxicol. 42, 135-163 (2002).
24. Impey, S., Obrietan, K. & Storm, D.R. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23, 11-14 (1999).
25. Davis, S., Vanhoutte, P., Pages, C., Caboche, J. & Laroche, S. The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J. Neurosci. 20, 4563-4572 (2000).
26. Benowitz, L.I. & Routtenberg, A. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20, 84-91 (1997).
27. Thorsell, A., Carlsson, K., Ekman, R. & Heilig, M. Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport 10, 3003-3007 (1999).
28. Luiten, P.G., Koolhaas, J.M., de Boer, S. & Koopmans, S.J. The cortico-medial amygdala in the central nervous system organization of agonistic behavior. Brain Res. 332, 283-297 (1985).
29. McEwen, B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22, 105-122 (1999).
30. McEwen, B.S. & Sapolsky, R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 5, 205-216 (1995).
31. McEwen, B.S. The neurobiology and neuroendocrinology of stress implications for post-traumatic stress disorder from a basic science perspective. Psychiatr. Clin. North Am. 25, 469-494 (2002).
32. Fanselow, M.S. & LeDoux, J.E. Why we think plasticity underlying Pavlovian fear conditioning occurs in the basolateral amygdala. Neuron 23, 229-232 (1999).
33. Rogan, M.T., Staubli, U.V. & LeDoux, J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390, 604-607 (1997).
34. Gualandris, A., Jones, T.E., Strickland, S. & Tsirka, S.E. Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J. Neurosci. 16, 2220-2225 (1996).
35. Parmer, R.J. et al. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release oft-PA. J. Biol. Chem. 272, 1976-1982 (1997).
36. Neuhoff, H., Roeper, J. & Schweizer, M. Activity-dependent formation of perforated synapses in cultured hippocampal neurons. Eur. J. Neurosci. 11, 4241-4250 (1999).
37. Nakagami, Y., Abe, K., Nishiyama, N. & Matsuki, N. Laminin degradation by plasmin regulates long-term potentiation. J. Neurosci. 20, 2003-2010 (2000).
38. Yepes, M. et al. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. J. Clin. Invest. 109, 1571-1578 (2002).
39. Huang, Y.Y. et al. Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc. Natl. Acad. Sci. USA 93, 8699-8704 (1996).
40. Frey, U., Muller, M. & Kuhl, D. A different form of long-lasting potentiation revealed in tissue plasminogen activator mutant mice. J. Neurosci. 16, 2057-2063 (1996).
41. Chapman, P.F. & Chattarji, S. Synaptic plasticity in the amygdala. in The Amygdala (ed. Aggleton, J.P.) 117-153 (Oxford Univ. Press, 2000)
42. Kim, Y.H., Park, J.H., Hong, S.H. & Koh, J.Y. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science 284, 647-650 (1999).
43. Zhuo, M. et al. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J. Neurosci. 20, 542-549 (2000).
44. Chen, Z.L. et al. Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J. Neurosci. 15, 5088-5097 (1995).
45. Schafe, G.E. et al. Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J. Neurosci. 20, 8177-8187 (2000).
46. Glowinski, J. & Iversen, L. Regional studies ofcatecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. Biochem. Pharmacol. 15, 977-987 (1966).